Jr. JosephSaseenJoseph J Saseen Jr.39.74688660000000-104.838256700000004199Saseen, JosephJ303/724-2656Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifierbibo:suffixNamename suffixAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:orcidIdORCID idvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 837431Authorship 840311Authorship 846434Authorship 118994325258088Wilson L, Nair KV, Saseen JJJournal of clinical hypertension (Greenwich, Conn.)Wilson L, Nair KV, Saseen JJ. Comparison of new-onset gout in adults prescribed chlorthalidone vs. hydrochlorothiazide for hypertension. J Clin Hypertens (Greenwich). 2014 Dec; 16(12):864-8.J Clin Hypertens (Greenwich)2014-09-25T00:00:002014Comparison of new-onset gout in adults prescribed chlorthalidone vs. hydrochlorothiazide for hypertension.Authorship 850732Authorship 852252Authorship 868111Authorship 903224Authorship 1211524Authorship 1214421Authorship 121651325348907Tuchscherer RM, Nair K, Ghushchyan V, Saseen JJAmerican journal of cardiovascular drugs : drugs, devices, and other interventionsTuchscherer RM, Nair K, Ghushchyan V, Saseen JJ. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database. Am J Cardiovasc Drugs. 2015 Feb; 15(1):27-34.Am J Cardiovasc Drugs2015-02-01T00:00:002015Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.25496048Saseen JJ, Ghushchyan V, Nair KVJournal of clinical hypertension (Greenwich, Conn.)Saseen JJ, Ghushchyan V, Nair KV. Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population. J Clin Hypertens (Greenwich). 2015 Feb; 17(2):134-40.J Clin Hypertens (Greenwich)2014-12-15T00:00:002014Comparing clinical effectiveness and drug toxicity with hydrochlorothiazide and chlorthalidone using two potency ratios in a managed care population.25591028Lowe RN, Vande Griend JP, Saseen JJThe Consultant pharmacist : the journal of the American Society of Consultant PharmacistsLowe RN, Vande Griend JP, Saseen JJ. Statins for the primary prevention of cardiovascular disease in the elderly. Consult Pharm. 2015 Jan; 30(1):20-30.Consult Pharm2015-01-01T00:00:002015Statins for the primary prevention of cardiovascular disease in the elderly.Authorship 124672225957374Vande Griend JP, Saseen JJ, Bislip D, Emsermann C, Conry C, Pace WDJournal of the American Board of Family Medicine : JABFMVande Griend JP, Saseen JJ, Bislip D, Emsermann C, Conry C, Pace WD. Prioritization of patients for comprehensive medication review by a clinical pharmacist in family medicine. J Am Board Fam Med. 2015 May-Jun; 28(3):418-24.J Am Board Fam Med2015-05-01T00:00:002015Prioritization of patients for comprehensive medication review by a clinical pharmacist in family medicine.Authorship 126738224727344Thompson LA, Saseen JJ, O'Bryant CL, Allen RR, Nair KVJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy PractitionersThompson LA, Saseen JJ, O'Bryant CL, Allen RR, Nair KV. Claims analysis of hypertension occurrence, severity changes and patterns of antihypertensive use in cancer patients receiving vascular endothelial growth factor inhibitors. J Oncol Pharm Pract. 2015 Aug; 21(4):258-67.J Oncol Pharm Pract2014-04-11T00:00:002014Claims analysis of hypertension occurrence, severity changes and patterns of antihypertensive use in cancer patients receiving vascular endothelial growth factor inhibitors.AnnaClausAnna Elizabeth Claus39.74688660000000-104.8382567000000010272Claus, AnnaAssociate ProfessorDanielleFixenDanielle Rhyne Fixen39.74688660000000-104.8382567000000010362Fixen, DanielleClinical Assoc Professor Authorship 135093326416950Zupec JF, Marrs JC, Saseen JJThe Annals of pharmacotherapyZupec JF, Marrs JC, Saseen JJ. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Ann Pharmacother. 2016 Jan; 50(1):17-21.Ann Pharmacother2015-09-28T00:00:002015Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations.Authorship 136943226611871Phillips E, Saseen JJJournal of pharmacy practicePhillips E, Saseen JJ. Current Controversies With Recent Cholesterol Treatment Guidelines. J Pharm Pract. 2016 Feb; 29(1):15-25.J Pharm Pract2015-11-25T00:00:002015Current Controversies With Recent Cholesterol Treatment Guidelines.SarahBillupsSarah Jane Billups39.74688660000000-104.8382567000000011081Billups, SarahClinical Assoc Professor Authorship 139243226932225Wiggins BS, Saseen JJ, Morris PBCurrent atherosclerosis reportsWiggins BS, Saseen JJ, Morris PB. Gemfibrozil in Combination with Statins-Is It Really Contraindicated? Curr Atheroscler Rep. 2016 Apr; 18(4):18.Curr Atheroscler Rep2016-04-01T00:00:002016Gemfibrozil in Combination with Statins-Is It Really Contraindicated?Authorship 140242226680558Fixen CW, Saseen JJ, Vande Griend JP, Linnebur SATherapeutic advances in cardiovascular diseaseFixen CW, Saseen JJ, Vande Griend JP, Linnebur SA. Assessment of blood pressure in patients with hypertension aged 60-79 years before and after the publication of the 2014 Eighth Joint National Committee report. Ther Adv Cardiovasc Dis. 2016 Apr; 10(2):67-73.Ther Adv Cardiovasc Dis2015-12-16T00:00:002015Assessment of blood pressure in patients with hypertension aged 60-79 years before and after the publication of the 2014 Eighth Joint National Committee report.Authorship 143923327144641Billups SJ, Olson KL, Saseen JJ, Irwin AN, Touchette DR, Chennault RR, Kurz DPharmacotherapyBillups SJ, Olson KL, Saseen JJ, Irwin AN, Touchette DR, Chennault RR, Kurz D. Evaluation of the Effect of A Structured Program to Guide Residents' Experience in Research (ASPIRE) on Pharmacy Residents' Knowledge, Confidence, and Attitude toward Research. Pharmacotherapy. 2016 06; 36(6):631-7.Pharmacotherapy2016-06-01T00:00:002016Evaluation of the Effect of A Structured Program to Guide Residents' Experience in Research (ASPIRE) on Pharmacy Residents' Knowledge, Confidence, and Attitude toward Research.10582832MacLaughlin EJ, Saseen JAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsMacLaughlin EJ, Saseen J. Importance of identifying foreign drugs. Am J Health Syst Pharm. 1999 Nov 15; 56(22):2349-50.Am J Health Syst Pharm1999-11-15T00:00:001999Importance of identifying foreign drugs.Authorship 1470366Authorship 147138227318031Wilson L, Saseen JJPharmacotherapyWilson L, Saseen JJ. Gouty Arthritis: A Review of Acute Management and Prevention. Pharmacotherapy. 2016 08; 36(8):906-22.Pharmacotherapy2016-07-22T00:00:002016Gouty Arthritis: A Review of Acute Management and Prevention.27536152McQueen RB, Ghushchyan V, Olufade T, Sheehan JJ, Nair KV, Saseen JJDiabetes, metabolic syndrome and obesity : targets and therapyMcQueen RB, Ghushchyan V, Olufade T, Sheehan JJ, Nair KV, Saseen JJ. Incremental increases in economic burden parallels cardiometabolic risk factors in the US. Diabetes Metab Syndr Obes. 2016; 9:233-41.Diabetes Metab Syndr Obes2016-08-02T00:00:002016Incremental increases in economic burden parallels cardiometabolic risk factors in the US.Authorship 147652427583122Trinkley KE, Malone DC, Nelson JA, Saseen JJTherapeutic advances in chronic diseaseTrinkley KE, Malone DC, Nelson JA, Saseen JJ. Prescribing attitudes, behaviors and opinions regarding metformin for patients with diabetes: a focus group study. Ther Adv Chronic Dis. 2016 Sep; 7(5):220-8.Ther Adv Chronic Dis2016-08-11T00:00:002016Prescribing attitudes, behaviors and opinions regarding metformin for patients with diabetes: a focus group study.10927711MacLaughlin EJ, Saseen JJ, Malone DCArchives of family medicineMacLaughlin EJ, Saseen JJ, Malone DC. Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy. Arch Fam Med. 2000 Aug; 9(8):722-6.Arch Fam Med2000-08-01T00:00:002000Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy.11034038Patel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DSPharmacotherapyPatel RJ, Witt DM, Saseen JJ, Tillman DJ, Wilkinson DS. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation. Pharmacotherapy. 2000 Oct; 20(10):1159-66.Pharmacotherapy2000-10-01T00:00:002000Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.11079287Mehos BM, Saseen JJ, MacLaughlin EJPharmacotherapyMehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000 Nov; 20(11):1384-9.Pharmacotherapy2000-11-01T00:00:002000Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension.8826565Saseen JJ, Carter BLThe Annals of pharmacotherapySaseen JJ, Carter BL. Dual calcium-channel blocker therapy in the treatment of hypertension. Ann Pharmacother. 1996 Jul-Aug; 30(7-8):802-10.Ann Pharmacother1996-07-01T00:00:001996Dual calcium-channel blocker therapy in the treatment of hypertension.Authorship 150269227754879Wiggins BS, Saseen JJ, Page RL, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PBCirculationWiggins BS, Saseen JJ, Page RL, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PB. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2016 11 22; 134(21):e468-e495.Circulation2016-10-17T00:00:002016Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.9208360Saseen JJ, Porter JA, Barnette DJ, Bauman JL, Zajac EJ, Carter BLJournal of clinical pharmacologySaseen JJ, Porter JA, Barnette DJ, Bauman JL, Zajac EJ, Carter BL. Postabsorption concentration peaks with brand-name and generic verapamil: a double-blind, crossover study in elderly hypertensive patients. J Clin Pharmacol. 1997 Jun; 37(6):526-34.J Clin Pharmacol1997-06-01T00:00:001997Postabsorption concentration peaks with brand-name and generic verapamil: a double-blind, crossover study in elderly hypertensive patients.12620167Saseen JJThe Journal of family practiceSaseen JJ. Does acetaminophen affect liver function in alcoholic patients? J Fam Pract. 2003 Mar; 52(3):187-8.J Fam Pract2003-03-01T00:00:002003Does acetaminophen affect liver function in alcoholic patients?12620170Saseen JJThe Journal of family practiceSaseen JJ. Is rate control better than rhythm control for atrial fibrillation in older high-risk patients? J Fam Pract. 2003 Mar; 52(3):192, 194.J Fam Pract2003-03-01T00:00:002003Is rate control better than rhythm control for atrial fibrillation in older high-risk patients?12967547Ball TA, Kerns JW, Nashelsky J, Saseen JThe Journal of family practiceBall TA, Kerns JW, Nashelsky J, Saseen J. Clinical inquiries. Do antiarrhythmics prevent sudden death in patients with heart failure? J Fam Pract. 2003 Sep; 52(9):719-21.J Fam Pract2003-09-01T00:00:002003Clinical inquiries. Do antiarrhythmics prevent sudden death in patients with heart failure?Authorship 155230228033742Kelly MS, Saseen JJ, Marrs JCTherapeutic advances in cardiovascular diseaseKelly MS, Saseen JJ, Marrs JC. Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendations. Ther Adv Cardiovasc Dis. 2017 Feb; 11(2):63-71.Ther Adv Cardiovasc Dis2016-12-30T00:00:002016Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendations.Authorship 155988528128669McQueen RB, Farahbakhshian S, Bell KF, Nair KV, Saseen JJJournal of medical economicsMcQueen RB, Farahbakhshian S, Bell KF, Nair KV, Saseen JJ. Economic burden of comorbid chronic kidney disease and diabetes. J Med Econ. 2017 Jun; 20(6):585-591.J Med Econ2017-02-14T00:00:002017Economic burden of comorbid chronic kidney disease and diabetes.14709273Sferra L, Kelsberg G, Dodson S, Saseen JThe Journal of family practiceSferra L, Kelsberg G, Dodson S, Saseen J. Clinical inquiries. Do ACE inhibitors prevent nephropathy in type 2 diabetes without proteinuria? J Fam Pract. 2004 Jan; 53(1):68-9.J Fam Pract2004-01-01T00:00:002004Clinical inquiries. Do ACE inhibitors prevent nephropathy in type 2 diabetes without proteinuria?15098804Bestul MB, McCollum M, Hansen LB, Saseen JJPharmacotherapyBestul MB, McCollum M, Hansen LB, Saseen JJ. Impact of the women's health initiative trial results on hormone replacement therapy. Pharmacotherapy. 2004 Apr; 24(4):495-9.Pharmacotherapy2004-04-01T00:00:002004Impact of the women's health initiative trial results on hormone replacement therapy.15189729Buescher JS, Meadows S, Saseen JThe Journal of family practiceBuescher JS, Meadows S, Saseen J. Clinical inquiries. Does acetaminophen and NSAID combined relieve osteoarthritis pain better than either alone? J Fam Pract. 2004 Jun; 53(6):501-3.J Fam Pract2004-06-01T00:00:002004Clinical inquiries. Does acetaminophen and NSAID combined relieve osteoarthritis pain better than either alone?5Other Faculty1Professor2Assoc Professor14989570Hansen LB, Saseen JJAmerican family physicianHansen LB, Saseen JJ. New contraceptive options: patient adherence and satisfaction. Am Fam Physician. 2004 Feb 15; 69(4):811-2, 815-6.Am Fam Physician2004-02-15T00:00:002004New contraceptive options: patient adherence and satisfaction.15000916Saseen JJThe Journal of family practiceSaseen JJ. Epinephrine is efficacious for outpatient treatment of bronchiolitis. J Fam Pract. 2004 Mar; 53(3):175-80.J Fam Pract2004-03-01T00:00:002004Epinephrine is efficacious for outpatient treatment of bronchiolitis.15972384Saseen JJAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsSaseen JJ. ASHP therapeutic position statement on the daily use of aspirin for preventing cardiovascular events. Am J Health Syst Pharm. 2005 Jul 01; 62(13):1398-405.Am J Health Syst Pharm2005-07-01T00:00:002005ASHP therapeutic position statement on the daily use of aspirin for preventing cardiovascular events.Authorship 160844428364370Wiggins BS, Lamprecht DG, Page RL, Saseen JJAmerican journal of cardiovascular drugs : drugs, devices, and other interventionsWiggins BS, Lamprecht DG, Page RL, Saseen JJ. Recommendations for Managing Drug-Drug Interactions with Statins and HIV Medications. Am J Cardiovasc Drugs. 2017 Oct; 17(5):375-389.Am J Cardiovasc Drugs2017-10-01T00:00:002017Recommendations for Managing Drug-Drug Interactions with Statins and HIV Medications.Authorship 161865328391913Graham JH, Sanchez RJ, Saseen JJ, Mallya UG, Panaccio MP, Evans MAJournal of clinical lipidologyGraham JH, Sanchez RJ, Saseen JJ, Mallya UG, Panaccio MP, Evans MA. Clinical and economic consequences of statin intolerance in the United States: Results from an integrated health system. J Clin Lipidol. 2017 Jan - Feb; 11(1):70-79.e1.J Clin Lipidol2016-10-12T00:00:002016Clinical and economic consequences of statin intolerance in the United States: Results from an integrated health system.16637798Murphy JE, Nappi JM, Bosso JA, Saseen JJ, Hemstreet BA, Halloran MA, Spinler SA, Welty TE, Dobesh PP, Chan LN, Garvin CG, Grunwald PE, Kamper CA, Sanoski CA, Witkowski PLPharmacotherapyMurphy JE, Nappi JM, Bosso JA, Saseen JJ, Hemstreet BA, Halloran MA, Spinler SA, Welty TE, Dobesh PP, Chan LN, Garvin CG, Grunwald PE, Kamper CA, Sanoski CA, Witkowski PL. American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy. 2006 May; 26(5):722-33.Pharmacotherapy2006-05-01T00:00:002006American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice.16882445Noviasky J, Lo V, Luft DD, Saseen JThe Journal of family practiceNoviasky J, Lo V, Luft DD, Saseen J. Clinical inquiries. Which medications can be split without compromising efficacy and safety? J Fam Pract. 2006 Aug; 55(8):707-8.J Fam Pract2006-08-01T00:00:002006Clinical inquiries. Which medications can be split without compromising efficacy and safety?17563046Marrs JC, Saseen JJAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsMarrs JC, Saseen JJ. Which patients are candidates for dipeptidyl peptidase IV inhibitors? Am J Health Syst Pharm. 2007 Jun; 64(12):1261.Am J Health Syst Pharm2007-06-01T00:00:002007Which patients are candidates for dipeptidyl peptidase IV inhibitors?17619646Turner CJ, Ellis S, Giles J, Maffeo C, Hansen L, Saseen JJ, Ulrich H, Valdez C, Altiere R, Bainbridge J, Page R, Sintek C, Vondracek S, Zadvorny E, Fish DAmerican journal of pharmaceutical educationTurner CJ, Ellis S, Giles J, Maffeo C, Hansen L, Saseen JJ, Ulrich H, Valdez C, Altiere R, Bainbridge J, Page R, Sintek C, Vondracek S, Zadvorny E, Fish D. A strategy to develop advanced pharmacy practice experiences. Am J Pharm Educ. 2007 Jun 15; 71(3):46.Am J Pharm Educ2007-06-15T00:00:002007A strategy to develop advanced pharmacy practice experiences.17669296Worriax JD, Yates JE, Flake D, Saseen JJThe Journal of family practiceWorriax JD, Yates JE, Flake D, Saseen JJ. Clinical inquiries. Alcoholic liver disease: is acetaminophen safe? J Fam Pract. 2007 Aug; 56(8):673-4.J Fam Pract2007-08-01T00:00:002007Clinical inquiries. Alcoholic liver disease: is acetaminophen safe?18041880Saseen JJPharmacotherapySaseen JJ. Putting new disease-modifying antirheumatic drugs into perspective. Pharmacotherapy. 2007 Dec; 27(12):1609-10.Pharmacotherapy2007-12-01T00:00:002007Putting new disease-modifying antirheumatic drugs into perspective.Authorship 1629091Authorship 1632093Authorship 163301328496265Saseen JJ, Linnebur SA, Borgelt LM, Trujillo J, Fish DN, Mueller SAmerican journal of pharmaceutical educationSaseen JJ, Linnebur SA, Borgelt LM, Trujillo J, Fish DN, Mueller S. A Pharmacotherapy Capstone Course to Target Student Learning and Programmatic Curricular Assessment. Am J Pharm Educ. 2017 Apr; 81(3):45.Am J Pharm Educ2017-04-01T00:00:002017A Pharmacotherapy Capstone Course to Target Student Learning and Programmatic Curricular Assessment.28515934Norman JL, Fixen DR, Saseen JJ, Saba LM, Linnebur SASAGE open medicineNorman JL, Fixen DR, Saseen JJ, Saba LM, Linnebur SA. Zolpidem prescribing practices before and after Food and Drug Administration required product labeling changes. SAGE Open Med. 2017; 5:2050312117707687.SAGE Open Med2017-05-05T00:00:002017Zolpidem prescribing practices before and after Food and Drug Administration required product labeling changes.28532784Orringer CE, Jacobson TA, Saseen JJ, Brown AS, Gotto AM, Ross JL, Underberg JAJournal of clinical lipidologyOrringer CE, Jacobson TA, Saseen JJ, Brown AS, Gotto AM, Ross JL, Underberg JA. Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association. J Clin Lipidol. 2017 Jul - Aug; 11(4):880-890.J Clin Lipidol2017-05-19T00:00:002017Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association.18447654Marrs JC, Saseen JJPharmacotherapyMarrs JC, Saseen JJ. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients. Pharmacotherapy. 2008 May; 28(5):562-9.Pharmacotherapy2008-05-01T00:00:002008Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients.19192975Nair KV, Tang B, Van Den Bos J, Zhang V, Saseen JJ, Naim A, Rahman MCurrent medical research and opinionNair KV, Tang B, Van Den Bos J, Zhang V, Saseen JJ, Naim A, Rahman M. Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. Curr Med Res Opin. 2009 Feb; 25(2):303-14.Curr Med Res Opin2009-02-01T00:00:002009Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations.Authorship 164701628638617Truong H, Kroehl ME, Lewis C, Pettigrew R, Bennett M, Saseen JJ, Trinkley KESAGE open medicineTruong H, Kroehl ME, Lewis C, Pettigrew R, Bennett M, Saseen JJ, Trinkley KE. Clinical pharmacists in primary care: Provider satisfaction and perceived impact on quality of care provided. SAGE Open Med. 2017; 5:2050312117713911.SAGE Open Med2017-06-13T00:00:002017Clinical pharmacists in primary care: Provider satisfaction and perceived impact on quality of care provided.Authorship 167667528815008Oung AB, Kosirog E, Chavez B, Brunner J, Saseen JJTherapeutic advances in chronic diseaseOung AB, Kosirog E, Chavez B, Brunner J, Saseen JJ. Evaluation of medication adherence in chronic disease at a federally qualified health center. Ther Adv Chronic Dis. 2017 Aug; 8(8-9):113-120.Ther Adv Chronic Dis2017-06-21T00:00:002017Evaluation of medication adherence in chronic disease at a federally qualified health center.20653359Marrs JC, Saseen JJPharmacotherapyMarrs JC, Saseen JJ. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. Pharmacotherapy. 2010 Aug; 30(8):823-9.Pharmacotherapy2010-08-01T00:00:002010Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.20879904Nair KV, Miller K, Park J, Allen RR, Saseen JJ, Biddle VPopulation health managementNair KV, Miller K, Park J, Allen RR, Saseen JJ, Biddle V. Prescription co-pay reduction program for diabetic employees. Popul Health Manag. 2010 Oct; 13(5):235-45.Popul Health Manag2010-10-01T00:00:002010Prescription co-pay reduction program for diabetic employees.21291705Linnebur SA, Capell WH, Saseen JJ, Wolfe P, Eckel RHJournal of clinical lipidologyLinnebur SA, Capell WH, Saseen JJ, Wolfe P, Eckel RH. Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations. J Clin Lipidol. 2007 Dec; 1(6):626-33.J Clin Lipidol2007-10-18T00:00:002007Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations.21436914Haines SL, DeHart RM, Hess KM, Marciniak MW, Mount JK, Phillips BB, Saseen JJ, Flynn AA, Zatzkin SWAmerican journal of pharmaceutical educationHaines SL, DeHart RM, Hess KM, Marciniak MW, Mount JK, Phillips BB, Saseen JJ, Flynn AA, Zatzkin SW. Report of the 2009-2010 Professional Affairs Committee: pharmacist integration in primary care and the role of academic pharmacy. Am J Pharm Educ. 2010 Dec 15; 74(10):S5.Am J Pharm Educ2010-12-15T00:00:002010Report of the 2009-2010 Professional Affairs Committee: pharmacist integration in primary care and the role of academic pharmacy.21382810Haines SL, DeHart RM, Flynn AA, Hess KM, Marciniak MW, Mount J, Phillips BB, Saseen JJ, Zatzkin SWJournal of the American Pharmacists Association : JAPhAHaines SL, DeHart RM, Flynn AA, Hess KM, Marciniak MW, Mount J, Phillips BB, Saseen JJ, Zatzkin SW. Academic pharmacy and patient-centered health care: a model to prepare the next generation of pharmacists. J Am Pharm Assoc (2003). 2011 Mar-Apr; 51(2):194-202.J Am Pharm Assoc (2003)2011-03-01T00:00:002011Academic pharmacy and patient-centered health care: a model to prepare the next generation of pharmacists.Authorship 172256529117750Wettergreen SA, Brunner J, Linnebur SA, Borgelt LM, Saseen JJMedical teacherWettergreen SA, Brunner J, Linnebur SA, Borgelt LM, Saseen JJ. Comparison of faculty assessment and students' self-assessment of performance during clinical case discussions in a pharmacotherapy capstone course. Med Teach. 2018 02; 40(2):193-198.Med Teach2017-11-09T00:00:002017Comparison of faculty assessment and students' self-assessment of performance during clinical case discussions in a pharmacotherapy capstone course.22298945Pesa JA, Van Den Bos J, Gray T, Hartsig C, McQueen RB, Saseen JJ, Nair KVPatient preference and adherencePesa JA, Van Den Bos J, Gray T, Hartsig C, McQueen RB, Saseen JJ, Nair KV. An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures. Patient Prefer Adherence. 2012; 6:63-72.Patient Prefer Adherence2012-01-18T00:00:002012An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures.22372031Nair KV, Frech-Tamas F, Jan S, Wolfe P, Allen RR, Saseen JJJournal of health care financeNair KV, Frech-Tamas F, Jan S, Wolfe P, Allen RR, Saseen JJ. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan. J Health Care Finance. 2011; 38(2):38-53.J Health Care Finance2011-01-01T00:00:002011Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.22570173Alford JC, Saseen JJ, Allen RR, Nair KVPharmacotherapyAlford JC, Saseen JJ, Allen RR, Nair KV. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions. Pharmacotherapy. 2012 Jul; 32(7):623-30.Pharmacotherapy2012-05-08T00:00:002012Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions.12613239Saseen JJ, Hansen LBAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsSaseen JJ, Hansen LB. What pharmacists need to know about the women's health initiative estrogen plus progestin trial. Am J Health Syst Pharm. 2003 Feb 01; 60(3):281-4.Am J Health Syst Pharm2003-02-01T00:00:002003What pharmacists need to know about the women's health initiative estrogen plus progestin trial.12665182Saseen JJ, MacLaughlin EJ, Westfall JMThe Journal of the American Board of Family PracticeSaseen JJ, MacLaughlin EJ, Westfall JM. Treatment of uncomplicated hypertension: are ACE inhibitors and calcium channel blockers as effective as diuretics and beta-blockers? J Am Board Fam Pract. 2003 Mar-Apr; 16(2):156-64.J Am Board Fam Pract2003-03-01T00:00:002003Treatment of uncomplicated hypertension: are ACE inhibitors and calcium channel blockers as effective as diuretics and beta-blockers?12737131Saseen J, MacLaughlin EJThe AIDS readerSaseen J, MacLaughlin EJ. Appetite stimulants and anabolic steroid therapy for AIDS wasting. AIDS Read. 1999 Sep; 9(6):398, 401-2, 407.AIDS Read1999-09-01T00:00:001999Appetite stimulants and anabolic steroid therapy for AIDS wasting.14693317Valuck RJ, Williams SA, MacArthur M, Saseen JJ, Nair KV, McCollum M, Ensor JEClinical therapeuticsValuck RJ, Williams SA, MacArthur M, Saseen JJ, Nair KV, McCollum M, Ensor JE. A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization. Clin Ther. 2003 Nov; 25(11):2936-57.Clin Ther2003-11-01T00:00:002003A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization.8675249Saseen JJ, Carter BL, Brown TE, Elliott WJ, Black HRHypertension (Dallas, Tex. : 1979)Saseen JJ, Carter BL, Brown TE, Elliott WJ, Black HR. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension. Hypertension. 1996 Jul; 28(1):109-14.Hypertension1996-07-01T00:00:001996Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.15755382Hull SK, Collins LJ, Saseen JJThe Journal of family practiceHull SK, Collins LJ, Saseen JJ. Clinical inquiries. How useful is high-sensitivity CRP as a risk factor for coronary artery disease? J Fam Pract. 2005 Mar; 54(3):268, 271-2.J Fam Pract2005-03-01T00:00:002005Clinical inquiries. How useful is high-sensitivity CRP as a risk factor for coronary artery disease?15939009Fisher M, Blackwell J, Saseen JThe Journal of family practiceFisher M, Blackwell J, Saseen J. Clinical inquiries. What is the best way to identify patients with white-coat hypertension? J Fam Pract. 2005 Jun; 54(6):549-50, 552.J Fam Pract2005-06-01T00:00:002005Clinical inquiries. What is the best way to identify patients with white-coat hypertension?15957142Joy MS, DeHart RM, Gilmartin C, Hachey DM, Hudson JQ, Pruchnicki M, Dumo P, Grabe DW, Saseen J, Zillich AJAmerican journal of kidney diseases : the official journal of the National Kidney FoundationJoy MS, DeHart RM, Gilmartin C, Hachey DM, Hudson JQ, Pruchnicki M, Dumo P, Grabe DW, Saseen J, Zillich AJ. Clinical pharmacists as multidisciplinary health care providers in the management of CKD: a joint opinion by the Nephrology and Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy. Am J Kidney Dis. 2005 Jun; 45(6):1105-18.Am J Kidney Dis2005-06-01T00:00:002005Clinical pharmacists as multidisciplinary health care providers in the management of CKD: a joint opinion by the Nephrology and Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy.16368926Nair KV, Saseen JJThe Annals of pharmacotherapyNair KV, Saseen JJ. Quality assessment of dyslipidemia in managed care: current best evidence should be used to benchmark quality. Ann Pharmacother. 2006 Jan; 40(1):124-7.Ann Pharmacother2005-12-20T00:00:002005Quality assessment of dyslipidemia in managed care: current best evidence should be used to benchmark quality.16379995Saseen JJ, Miller AEEvidence-based cardiovascular medicineSaseen JJ, Miller AE. Aggressive statin therapy in disease management clinics reduces cardiovascular morbidity for people with coronary heart disease. Commentary. Evid Based Cardiovasc Med. 2005 Mar; 9(1):76-8.Evid Based Cardiovasc Med2005-03-01T00:00:002005Aggressive statin therapy in disease management clinics reduces cardiovascular morbidity for people with coronary heart disease. Commentary.16914627Murphy JE, Saseen JJ, Nappi J, Bosso JAAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsMurphy JE, Saseen JJ, Nappi J, Bosso JA. Comments on draft of work force document. Am J Health Syst Pharm. 2006 Sep 01; 63(17):1592.Am J Health Syst Pharm2006-09-01T00:00:002006Comments on draft of work force document.17220158Hansen LB, Saseen JJ, Westfall JM, Holcomb S, Nuzum DS, Pace WDJoint Commission journal on quality and patient safetyHansen LB, Saseen JJ, Westfall JM, Holcomb S, Nuzum DS, Pace WD. Evaluating sample medications in primary care: a practice-based research network study. Jt Comm J Qual Patient Saf. 2006 Dec; 32(12):688-92.Jt Comm J Qual Patient Saf2006-12-01T00:00:002006Evaluating sample medications in primary care: a practice-based research network study.17253917Hansen LB, Saseen JJ, Teal SBPharmacotherapyHansen LB, Saseen JJ, Teal SB. Levonorgestrel-only dosing strategies for emergency contraception. Pharmacotherapy. 2007 Feb; 27(2):278-84.Pharmacotherapy2007-02-01T00:00:002007Levonorgestrel-only dosing strategies for emergency contraception.17304872Pejic RN, Jamieson B, Saseen JAmerican family physicianPejic RN, Jamieson B, Saseen J. Which lipoprotein measurements are clinically useful? Am Fam Physician. 2007 Feb 01; 75(3):387-8.Am Fam Physician2007-02-01T00:00:002007Which lipoprotein measurements are clinically useful?12013367Linnebur SA, Saseen JJ, Pace WDPharmacotherapyLinnebur SA, Saseen JJ, Pace WD. Venlafaxine-associated vaginal bleeding. Pharmacotherapy. 2002 May; 22(5):652-5.Pharmacotherapy2002-05-01T00:00:002002Venlafaxine-associated vaginal bleeding.12019062Kill J, Saseen JJThe Journal of family practiceKill J, Saseen JJ. Does use of oxytocin and dinoprostone inserts shorten labor more than use of oxytocin after removal of dinoprostone? J Fam Pract. 2002 May; 51(5):479.J Fam Pract2002-05-01T00:00:002002Does use of oxytocin and dinoprostone inserts shorten labor more than use of oxytocin after removal of dinoprostone?14653986Daugird AJ, Crowell K, Saseen JThe Journal of family practiceDaugird AJ, Crowell K, Saseen J. Clinical inquiries. Do statins cause myopathy? J Fam Pract. 2003 Dec; 52(12):973-7.J Fam Pract2003-12-01T00:00:002003Clinical inquiries. Do statins cause myopathy?15521793Sullivan PW, Valuck R, Saseen J, MacFall HMCNS drugsSullivan PW, Valuck R, Saseen J, MacFall HM. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions. CNS Drugs. 2004; 18(13):911-32.CNS Drugs2004-01-01T00:00:002004A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.15690249Bazaldua O, Ables AZ, Dickerson LM, Hansen L, Harris I, Hoehns J, Jackson E, Kraus C, Mayville H, Saseen JJFamily medicineBazaldua O, Ables AZ, Dickerson LM, Hansen L, Harris I, Hoehns J, Jackson E, Kraus C, Mayville H, Saseen JJ. Suggested guidelines for pharmacotherapy curricula in family medicine residency training: recommendations from the Society of Teachers of Family Medicine Group on Pharmacotherapy. Fam Med. 2005 Feb; 37(2):99-104.Fam Med2005-02-01T00:00:002005Suggested guidelines for pharmacotherapy curricula in family medicine residency training: recommendations from the Society of Teachers of Family Medicine Group on Pharmacotherapy.15755386Saseen JJ, Turner C, Russell RGThe Journal of family practiceSaseen JJ, Turner C, Russell RG. Clinical inquiries. What is the best regimen for newly diagnosed hypertension? J Fam Pract. 2005 Mar; 54(3):281-2.J Fam Pract2005-03-01T00:00:002005Clinical inquiries. What is the best regimen for newly diagnosed hypertension?15767229Zillich AJ, Saseen JJ, Dehart RM, Dumo P, Grabe DW, Gilmartin C, Hachey DM, Hudson JQ, Pruchnicki MC, Joy MSPharmacotherapyZillich AJ, Saseen JJ, Dehart RM, Dumo P, Grabe DW, Gilmartin C, Hachey DM, Hudson JQ, Pruchnicki MC, Joy MS. Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy. Pharmacotherapy. 2005 Jan; 25(1):123-43.Pharmacotherapy2005-01-01T00:00:002005Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy.12850 E. Montview Bouldervard2SPPSSkaggs School of Pharmacy12850 E. Montview BouldervardAurora80045-2605CO16388773Saseen J, Tweed E, Crawford PThe Journal of family practiceSaseen J, Tweed E, Crawford P. Clinical inquiries. What are effective medication combinations for dyslipidemia? J Fam Pract. 2006 Jan; 55(1):70-2.J Fam Pract2006-01-01T00:00:002006Clinical inquiries. What are effective medication combinations for dyslipidemia?16388774Lochner J, Rugge B, Judkins D, Saseen JThe Journal of family practiceLochner J, Rugge B, Judkins D, Saseen J. Clinical inquiries. How effective are lifestyle changes for controlling hypertension? J Fam Pract. 2006 Jan; 55(1):73-4.J Fam Pract2006-01-01T00:00:002006Clinical inquiries. How effective are lifestyle changes for controlling hypertension?16510063Lo V, Meadows SE, Saseen JThe Journal of family practiceLo V, Meadows SE, Saseen J. When should COX-2 selective NSAIDs be used for osteoarthritis and rheumatoid arthritis? J Fam Pract. 2006 Mar; 55(3):260-2.J Fam Pract2006-03-01T00:00:002006When should COX-2 selective NSAIDs be used for osteoarthritis and rheumatoid arthritis?18823219Vande Griend JP, Saseen JJPharmacotherapyVande Griend JP, Saseen JJ. Combination antiplatelet agents for secondary prevention of ischemic stroke. Pharmacotherapy. 2008 Oct; 28(10):1233-42.Pharmacotherapy2008-10-01T00:00:002008Combination antiplatelet agents for secondary prevention of ischemic stroke.17125444Saseen JJ, Grady SE, Hansen LB, Hodges BM, Kovacs SJ, Martinez LD, Murphy JE, Page RL, Reichert MG, Stringer KA, Taylor CTPharmacotherapySaseen JJ, Grady SE, Hansen LB, Hodges BM, Kovacs SJ, Martinez LD, Murphy JE, Page RL, Reichert MG, Stringer KA, Taylor CT. Future clinical pharmacy practitioners should be board-certified specialists. Pharmacotherapy. 2006 Dec; 26(12):1816-25.Pharmacotherapy2006-12-01T00:00:002006Future clinical pharmacy practitioners should be board-certified specialists.19369897Nair KV, Park J, Wolfe P, Saseen JJ, Allen RR, Ganguly RJournal of occupational and environmental medicineNair KV, Park J, Wolfe P, Saseen JJ, Allen RR, Ganguly R. Consumer-driven health plans: impact on utilization and expenditures for chronic disease sufferers. J Occup Environ Med. 2009 May; 51(5):594-603.J Occup Environ Med2009-05-01T00:00:002009Consumer-driven health plans: impact on utilization and expenditures for chronic disease sufferers.17403332Sontheimer D, Hitchcock K, Saseen JThe Journal of family practiceSontheimer D, Hitchcock K, Saseen J. Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension? J Fam Pract. 2007 Apr; 56(4):312-4.J Fam Pract2007-04-01T00:00:002007Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?18447653Miller AE, Hansen LB, Saseen JJPharmacotherapyMiller AE, Hansen LB, Saseen JJ. Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients. Pharmacotherapy. 2008 May; 28(5):553-61.Pharmacotherapy2008-05-01T00:00:002008Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients.21291814Vande Griend JP, Saseen JJJournal of clinical lipidologyVande Griend JP, Saseen JJ. Low-density lipoprotein cholesterol goal attainment in high-risk family medicine patients. J Clin Lipidol. 2009 May-Jun; 3(3):195-200.J Clin Lipidol2009-05-05T00:00:002009Low-density lipoprotein cholesterol goal attainment in high-risk family medicine patients.21573051Nair KV, Belletti DA, Doyle JJ, Allen RR, McQueen RB, Saseen JJ, Vande Griend J, Patel JV, McQueen A, Jan SPatient preference and adherenceNair KV, Belletti DA, Doyle JJ, Allen RR, McQueen RB, Saseen JJ, Vande Griend J, Patel JV, McQueen A, Jan S. Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey. Patient Prefer Adherence. 2011 Apr 29; 5:195-206.Patient Prefer Adherence2011-04-29T00:00:002011Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey.22042809Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KVHypertension (Dallas, Tex. : 1979)Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011 Dec; 58(6):1008-13.Hypertension2011-10-31T00:00:002011Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.22829689Saseen JJ, Agashivala N, Allen RR, Ghushchyan V, Yadao AM, Nair KVRheumatology (Oxford, England)Saseen JJ, Agashivala N, Allen RR, Ghushchyan V, Yadao AM, Nair KV. Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks. Rheumatology (Oxford). 2012 Nov; 51(11):2004-12.Rheumatology (Oxford)2012-07-23T00:00:002012Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks.22825226Anderson SL, Trujillo JM, McDermott M, Saseen JJJournal of the American Pharmacists Association : JAPhAAnderson SL, Trujillo JM, McDermott M, Saseen JJ. Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):466-71.J Am Pharm Assoc (2003)2012-07-01T00:00:002012Determining predictors of response to exenatide in type 2 diabetes.23541707Libby AM, Fish DN, Hosokawa PW, Linnebur SA, Metz KR, Nair KV, Saseen JJ, Vande Griend JP, Vu SP, Hirsch JDClinical therapeuticsLibby AM, Fish DN, Hosokawa PW, Linnebur SA, Metz KR, Nair KV, Saseen JJ, Vande Griend JP, Vu SP, Hirsch JD. Patient-level medication regimen complexity across populations with chronic disease. Clin Ther. 2013 Apr; 35(4):385-398.e1.Clin Ther2013-03-29T00:00:002013Patient-level medication regimen complexity across populations with chronic disease.23649678Thompson A, Vande Griend JP, Linnebur SA, Saseen JJThe Consultant pharmacist : the journal of the American Society of Consultant PharmacistsThompson A, Vande Griend JP, Linnebur SA, Saseen JJ. Evaluation of type 2 diabetes mellitus medication management and control in older adults. Consult Pharm. 2013 May; 28(5):296-306.Consult Pharm2013-05-01T00:00:002013Evaluation of type 2 diabetes mellitus medication management and control in older adults.Authorship 1737788Authorship 1745695Authorship 174605229233374Nuffer W, Botts S, Franson K, Gilliam E, Knutsen R, Nuffer M, O'Brien E, Saseen J, Thompson M, Vande Griend J, Willis RCurrents in pharmacy teaching & learningNuffer W, Botts S, Franson K, Gilliam E, Knutsen R, Nuffer M, O'Brien E, Saseen J, Thompson M, Vande Griend J, Willis R. Curriculum renewal: Alignment of introductory pharmacy practice experiences with didactic course content. Curr Pharm Teach Learn. 2017 Nov; 9(6):1063-1070.Curr Pharm Teach Learn2017-09-05T00:00:002017Curriculum renewal: Alignment of introductory pharmacy practice experiences with didactic course content.29233407Anderson HD, Saseen JJCurrents in pharmacy teaching & learningAnderson HD, Saseen JJ. The importance of clinical research skills according to PharmD students, first-year residents, and residency directors. Curr Pharm Teach Learn. 2017 Mar - Apr; 9(2):224-229.Curr Pharm Teach Learn2017-02-01T00:00:002017The importance of clinical research skills according to PharmD students, first-year residents, and residency directors.29278980Vande Griend J, Fixen DR, Fixen CW, Zupec J, Saseen JJJournal of pharmacy practiceVande Griend J, Fixen DR, Fixen CW, Zupec J, Saseen JJ. Clinic-Level Population Health Intervention by PGY2 Ambulatory Care Pharmacy Residents to Optimize Medication Management in a Self-Insured Employer Health Plan Population. J Pharm Pract. 2018 Feb; 31(1):52-57.J Pharm Pract2017-03-14T00:00:002017Clinic-Level Population Health Intervention by PGY2 Ambulatory Care Pharmacy Residents to Optimize Medication Management in a Self-Insured Employer Health Plan Population.Authorship 1749501Authorship 175026528464300Saseen JJ, Ripley TL, Bondi D, Burke JM, Cohen LJ, McBane S, McConnell KJ, Sackey B, Sanoski C, Simonyan A, Taylor J, Vande Griend JPPharmacotherapySaseen JJ, Ripley TL, Bondi D, Burke JM, Cohen LJ, McBane S, McConnell KJ, Sackey B, Sanoski C, Simonyan A, Taylor J, Vande Griend JP. ACCP Clinical Pharmacist Competencies. Pharmacotherapy. 2017 May; 37(5):630-636.Pharmacotherapy2017-05-02T00:00:002017ACCP Clinical Pharmacist Competencies.28884591Uzal NE, Chavez B, Kosirog ER, Billups SJ, Saseen JJThe Annals of pharmacotherapyUzal NE, Chavez B, Kosirog ER, Billups SJ, Saseen JJ. Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers. Ann Pharmacother. 2018 02; 52(2):160-165.Ann Pharmacother2017-09-08T00:00:002017Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers.Authorship 183498529941536Moore GD, Kosirog ER, Vande Griend JP, Freund JE, Saseen JJAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsMoore GD, Kosirog ER, Vande Griend JP, Freund JE, Saseen JJ. Expansion of clinical pharmacist positions through sustainable funding. Am J Health Syst Pharm. 2018 Jul 01; 75(13):978-981.Am J Health Syst Pharm2018-07-01T00:00:002018Expansion of clinical pharmacist positions through sustainable funding.Authorship 1844585Authorship 184600230009553Billups SJ, Saseen JJ, Vande Griend JP, Schilling LMJournal of clinical hypertension (Greenwich, Conn.)Billups SJ, Saseen JJ, Vande Griend JP, Schilling LM. Blood pressure control rates measured in specialty vs primary care practices within a large integrated health system. J Clin Hypertens (Greenwich). 2018 09; 20(9):1253-1259.J Clin Hypertens (Greenwich)2018-07-15T00:00:002018Blood pressure control rates measured in specialty vs primary care practices within a large integrated health system.30019916Pai AB, Divine H, Marciniak M, Morreale A, Saseen JJ, Say K, Segal AR, Norton JM, Narva ASThe Annals of pharmacotherapyPai AB, Divine H, Marciniak M, Morreale A, Saseen JJ, Say K, Segal AR, Norton JM, Narva AS. Need for a Judicious Use of Nonsteroidal Anti-inflammatory Drugs to Avoid Community-Acquired Acute Kidney Injury. Ann Pharmacother. 2019 01; 53(1):95-100.Ann Pharmacother2018-07-18T00:00:002018Need for a Judicious Use of Nonsteroidal Anti-inflammatory Drugs to Avoid Community-Acquired Acute Kidney Injury.MarcBonacaMarc Peter Bonaca39.74801570000000-104.8344263000000014508Bonaca, MarcProfessorD006973Disorders43912450.511409HypertensionAuthorship 186758230140163Claus LW, Saseen JJPatient related outcome measuresClaus LW, Saseen JJ. Patient considerations in the management of gout and role of combination treatment with lesinurad. Patient Relat Outcome Meas. 2018; 9:231-238.Patient Relat Outcome Meas2018-07-18T00:00:002018Patient considerations in the management of gout and role of combination treatment with lesinurad.Authorship 187560530181847Trinkley KE, Anderson HD, Nair KV, Malone DC, Saseen JJTherapeutic advances in chronic diseaseTrinkley KE, Anderson HD, Nair KV, Malone DC, Saseen JJ. Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis. Ther Adv Chronic Dis. 2018 Sep; 9(9):179-190.Ther Adv Chronic Dis2018-06-13T00:00:002018Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis.Authorship 189617730314552Payne MH, Tuchscherer RM, Billups SJ, Chavez B, Kosirog E, Petrie JL, Saseen JJCurrents in pharmacy teaching & learningPayne MH, Tuchscherer RM, Billups SJ, Chavez B, Kosirog E, Petrie JL, Saseen JJ. Changes in pharmacy students' perceptions of underserved populations after a six-week clinical rotation in a federally qualified health center clinic. Curr Pharm Teach Learn. 2018 08; 10(8):1149-1153.Curr Pharm Teach Learn2018-06-19T00:00:002018Changes in pharmacy students' perceptions of underserved populations after a six-week clinical rotation in a federally qualified health center clinic.Authorship 19094420Authorship 1909572030423391Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah JJournal of the American College of CardiologyGrundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2019 06 25; 73(24):3168-3209.J Am Coll Cardiol2018-11-10T00:00:0020182018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines.30423393Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah JJournal of the American College of CardiologyGrundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2019 06 25; 73(24):e285-e350.J Am Coll Cardiol2018-11-10T00:00:0020182018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines.Authorship 1924892030565953Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah JCirculationGrundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 06 18; 139(25):e1046-e1081.Circulation2018-11-10T00:00:0020182018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Authorship 1926332030586774Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah JCirculationGrundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC, Sperling L, Virani SS, Yeboah J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 06 18; 139(25):e1082-e1143.Circulation2018-11-10T00:00:0020182018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.CHA/PA ProgramAuthorship 193971530643309Blackmer AB, Thompson M, Brunner JM, Patel T, Saseen JJAmerican journal of pharmaceutical educationBlackmer AB, Thompson M, Brunner JM, Patel T, Saseen JJ. Implementation and Assessment of a Novel APPE Intersession Course to Assess Near-Terminal Student Competence. Am J Pharm Educ. 2018 12; 82(10):6460.Am J Pharm Educ2018-12-01T00:00:002018Implementation and Assessment of a Novel APPE Intersession Course to Assess Near-Terminal Student Competence.D010595Living Beings1082450.805425PharmacistsAuthorship 200226531054591Huntsberry AM, Linnebur SA, Fixen DR, Saba LM, Saseen JJThe Senior care pharmacistHuntsberry AM, Linnebur SA, Fixen DR, Saba LM, Saseen JJ. Effects of Chronic Proton-Pump Inhibitor Use on Kidney Function in Older Adults. Sr Care Pharm. 2019 May 01; 34(5):325-333.Sr Care Pharm2019-05-01T00:00:002019Effects of Chronic Proton-Pump Inhibitor Use on Kidney Function in Older Adults.D019161Chemicals & Drugs1514100.7142Hydroxymethylglutaryl-CoA Reductase InhibitorsAuthorship 201662531168286Rivich J, Kosirog ER, Billups SJ, Petrie JL, Saseen JJDiabetes spectrum : a publication of the American Diabetes AssociationRivich J, Kosirog ER, Billups SJ, Petrie JL, Saseen JJ. Social and Psychosocial Determinants of Health Associated With Uncontrolled Diabetes in a Federally Qualified Health Center Population. Diabetes Spectr. 2019 May; 32(2):145-151.Diabetes Spectr2019-05-01T00:00:002019Social and Psychosocial Determinants of Health Associated With Uncontrolled Diabetes in a Federally Qualified Health Center Population.REN GENERAL OPERATIONSAuthorship 202961231229021Braun LT, Saseen JJ, Orringer CE, Stone NJ, Guyton JRJournal of clinical lipidologyBraun LT, Saseen JJ, Orringer CE, Stone NJ, Guyton JR. JCL roundtable. The 2018 AHA/ACC/Multisociety Cholesterol Guidelines: Process and product. J Clin Lipidol. 2019 May - Jun; 13(3):345-355.J Clin Lipidol2019-05-01T00:00:002019JCL roundtable. The 2018 AHA/ACC/Multisociety Cholesterol Guidelines: Process and product.D002318Disorders49918590.419492Cardiovascular DiseasesAuthorship 2036111131256717Derington CG, Gums TH, Bress AP, Herrick JS, Greene TH, Moran AE, Weintraub WS, Kronish IM, Morisky DE, Trinkley KE, Saseen JJ, Reynolds K, Bates JT, Berlowitz DR, Chang TI, Chonchol M, Cushman WC, Foy CG, Herring CT, Katz LA, Krousel-Wood M, Pajewski NM, Tamariz L, King JBHypertension (Dallas, Tex. : 1979)Derington CG, Gums TH, Bress AP, Herrick JS, Greene TH, Moran AE, Weintraub WS, Kronish IM, Morisky DE, Trinkley KE, Saseen JJ, Reynolds K, Bates JT, Berlowitz DR, Chang TI, Chonchol M, Cushman WC, Foy CG, Herring CT, Katz LA, Krousel-Wood M, Pajewski NM, Tamariz L, King JB. Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT. Hypertension. 2019 Aug; 74(2):267-275.Hypertension2019-07-01T00:00:002019Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT.Authorship 2041131131281070Robinson JG, Jayanna MB, Brown AS, Aspry K, Orringer C, Gill EA, Goldberg A, Jones LK, Maki K, Dixon DL, Saseen JJ, Soffer DJournal of clinical lipidologyRobinson JG, Jayanna MB, Brown AS, Aspry K, Orringer C, Gill EA, Goldberg A, Jones LK, Maki K, Dixon DL, Saseen JJ, Soffer D. Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association. J Clin Lipidol. 2019 Jul - Aug; 13(4):525-537.J Clin Lipidol2019-05-16T00:00:002019Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association.D000959Chemicals & Drugs1704650.739959Antihypertensive AgentsSOM-FM General OperationsSOM-MEDSOM-PEDSSOP-AdministrationGeneral OperationsCardiologyUniversity of Colorado Denver - Anschutz Medical CampusGregorySchwartzGregory G Schwartz39.74515960000000-104.84062800000000108Schwartz, GregoryProfessorStephenDanielsStephen R Daniels39.74403510000000-104.836059400000002409Daniels, StephenProfessorAuthorship 111053RichardJohnsonRichard J Johnson39.74515960000000-104.840628000000003114Johnson, RichardProfessor4.612910.00820656448research areas2.516580.019524443coauthor of110.88620.89360similar to11154selected publicationsPhilipReiganPhilip Reigan39.74688660000000-104.838256700000004259Reigan, PhilipAssociate ProfessorJoelMarrsJoel Christoffer Marrs39.74688660000000-104.838256700000004262Marrs, Joel0000-0003-0392-3866Assoc Professor-ClinicalKavitaNairKavita Venugcpal Nair39.74688660000000-104.838256700000004208Nair, KavitaProfessorJaredBrownJared Michael Brown39.74688660000000-104.838256700000007164Brown, JaredProfessorSunnyLinneburSunny Anne Linnebur39.74688660000000-104.838256700000004221Linnebur, SunnyProfessorKatyTrinkleyKaty E Trinkley39.74688660000000-104.838256700000005235Trinkley, KatyAssociate ProfessorFrederickMasoudiFrederick A Masoudi39.74515960000000-104.84062800000000939Masoudi, FrederickAffiliate - DHHAAuthorship 117403Authorship 122614DmitriSimbergDmitri Simberg39.74688660000000-104.838256700000007751Simberg, DmitriProfessorAuthorship 211186531694390Snellings MS, Linnebur SA, Pearson SM, Wallace JI, Saseen JJ, Fixen DRThe Annals of pharmacotherapySnellings MS, Linnebur SA, Pearson SM, Wallace JI, Saseen JJ, Fixen DR. Effectiveness of Methenamine for UTI Prevention in Older Adults. Ann Pharmacother. 2020 04; 54(4):359-363.Ann Pharmacother2019-11-06T00:00:002019Effectiveness of Methenamine for UTI Prevention in Older Adults.Authorship 213663331897259Fink RM, Mooney EV, Saseen JJ, Billups SJPharmacy practiceFink RM, Mooney EV, Saseen JJ, Billups SJ. A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center. Pharm Pract (Granada). 2019 Oct-Dec; 17(4):1618.Pharm Pract (Granada)2019-12-03T00:00:002019A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center.Authorship 146601Authorship 217325632148129Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress APHypertension (Dallas, Tex. : 1979)Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress AP. Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016. Hypertension. 2020 04; 75(4):973-981.Hypertension2020-03-09T00:00:002020Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016.Authorship 150574Authorship 221965632537640Billups SJ, Hatlee IP, Claus LW, English AF, Petersen NR, Saseen JJAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsBillups SJ, Hatlee IP, Claus LW, English AF, Petersen NR, Saseen JJ. Can pharmacists reduce inappropriate emergency department utilization? Am J Health Syst Pharm. 2020 07 07; 77(14):1153-1157.Am J Health Syst Pharm2020-07-07T00:00:002020Can pharmacists reduce inappropriate emergency department utilization?Authorship 224957332752194Patel TC, Malhotra JV, Saseen JJPharmacy (Basel, Switzerland)Patel TC, Malhotra JV, Saseen JJ. Advancing Pharm. D. Training in Egypt through a Structured Preceptor Development Program. Pharmacy (Basel). 2020 Aug 01; 8(3).Pharmacy (Basel)2020-08-01T00:00:002020Advancing Pharm. D. Training in Egypt through a Structured Preceptor Development Program.Authorship 225436232803572Maes ML, Saseen JJ, Wright G, Claus LWClinical rheumatologyMaes ML, Saseen JJ, Wright G, Claus LW. Utilization of acute gout prophylaxis in the real world: a retrospective database cohort analysis. Clin Rheumatol. 2021 Mar; 40(3):1017-1026.Clin Rheumatol2020-08-15T00:00:002020Utilization of acute gout prophylaxis in the real world: a retrospective database cohort analysis.Authorship 228202432978094Tunoa JA, Billups SJ, Lowe RN, Saseen JJJournal of clinical lipidologyTunoa JA, Billups SJ, Lowe RN, Saseen JJ. Early impact of the 2018 AHA/ACC/multisociety cholesterol guideline on lipid monitoring after statin initiation. J Clin Lipidol. 2020 Nov - Dec; 14(6):784-790.J Clin Lipidol2020-09-15T00:00:002020Early impact of the 2018 AHA/ACC/multisociety cholesterol guideline on lipid monitoring after statin initiation.Authorship 2291385Authorship 2330182Authorship 232543333377525Cheng V, Billups SJ, Saseen JJHeadacheCheng V, Billups SJ, Saseen JJ. Prescribing practices of migraine-specific pharmacotherapy associated with emergency department use for migraine. Headache. 2021 Mar; 61(3):455-461.Headache2020-12-30T00:00:002020Prescribing practices of migraine-specific pharmacotherapy associated with emergency department use for migraine.33092440Orringer CE, Tokgozoglu L, Maki KC, Ray KK, Saseen JJ, Catapano ALJournal of the American Heart AssociationOrringer CE, Tokgozoglu L, Maki KC, Ray KK, Saseen JJ, Catapano AL. Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations. J Am Heart Assoc. 2020 11 03; 9(21):e018189.J Am Heart Assoc2020-10-23T00:00:002020Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations.33384242Dixon DL, Saseen JJJournal of the American Pharmacists Association : JAPhADixon DL, Saseen JJ. Pharmacist-administered long-acting injectable PCSK9 service: A solution to improve patient access and adherence. J Am Pharm Assoc (2003). 2021 May-Jun; 61(3):e83-e85.J Am Pharm Assoc (2003)2020-12-29T00:00:002020Pharmacist-administered long-acting injectable PCSK9 service: A solution to improve patient access and adherence.Authorship 2384636Authorship 238917333854754Varshney N, Billups SJ, Saseen JJ, Fixen CWTherapeutic advances in drug safetyVarshney N, Billups SJ, Saseen JJ, Fixen CW. Sodium-glucose cotransporter-2 inhibitors and risk for genitourinary infections in older adults with type 2 diabetes. Ther Adv Drug Saf. 2021; 12:2042098621997703.Ther Adv Drug Saf2021-03-29T00:00:002021Sodium-glucose cotransporter-2 inhibitors and risk for genitourinary infections in older adults with type 2 diabetes.33818688Ballantyne CM, Bays H, Catapano AL, Goldberg A, Ray KK, Saseen JJCardiovascular drugs and therapyBallantyne CM, Bays H, Catapano AL, Goldberg A, Ray KK, Saseen JJ. Role of Bempedoic Acid in Clinical Practice. Cardiovasc Drugs Ther. 2021 08; 35(4):853-864.Cardiovasc Drugs Ther2021-04-05T00:00:002021Role of Bempedoic Acid in Clinical Practice.Authorship 172837Authorship 175342Authorship 239605633871715Ballantyne CM, Bays H, Catapano AL, Goldberg A, Ray KK, Saseen JJCardiovascular drugs and therapyBallantyne CM, Bays H, Catapano AL, Goldberg A, Ray KK, Saseen JJ. Correction to: Role of Bempedoic Acid in Clinical Practice. Cardiovasc Drugs Ther. 2021 Aug; 35(4):865.Cardiovasc Drugs Ther2021-08-01T00:00:002021Correction to: Role of Bempedoic Acid in Clinical Practice.Authorship 241402334088808Leggott K, Willis L, Saseen J, Burakoff A, Fish D, Oberst-Walsh L, Cook K, Thomas JFJournal of the American Board of Family Medicine : JABFMLeggott K, Willis L, Saseen J, Burakoff A, Fish D, Oberst-Walsh L, Cook K, Thomas JF. A Just-in-Time Implementation of an Extension for Community Health Outcomes (ECHO) Program for Support of Primary Care During the COVID-19 Pandemic. J Am Board Fam Med. 2021 May-Jun; 34(3):481-488.J Am Board Fam Med2021-05-01T00:00:002021A Just-in-Time Implementation of an Extension for Community Health Outcomes (ECHO) Program for Support of Primary Care During the COVID-19 Pandemic.Authorship 178576Authorship 243620434221204Stewart MP, Fink R, Kosirog E, Saseen JJPharmacy practiceStewart MP, Fink R, Kosirog E, Saseen JJ. Bridging health disparities: a national survey of ambulatory care pharmacists in underserved areas. Pharm Pract (Granada). 2021 Apr-Jun; 19(2):2359.Pharm Pract (Granada)2021-05-29T00:00:002021Bridging health disparities: a national survey of ambulatory care pharmacists in underserved areas.Authorship 2448455Authorship 2494208Authorship 2452732Authorship 2510641034662571Zheutlin AR, Derington CG, King JB, Berchie RO, Herrick JS, Dixon DL, Cohen JB, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress APAmerican heart journalZheutlin AR, Derington CG, King JB, Berchie RO, Herrick JS, Dixon DL, Cohen JB, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress AP. Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018. Am Heart J. 2022 06; 248:150-159.Am Heart J2021-10-16T00:00:002021Factors associated with antihypertensive monotherapy among US adults with treated hypertension and uncontrolled blood pressure overall and by race/ethnicity, National Health and Nutrition Examination Survey 2013-2018.34381278Plakogiannis R, Saseen JJ, Stefanidis AHospital pharmacyPlakogiannis R, Saseen JJ, Stefanidis A. Pharmacists' Utilization of Non-HDL-C Levels in Managing Patients With Lipid Disorders. Hosp Pharm. 2021 Aug; 56(4):378-383.Hosp Pharm2020-03-06T00:00:002020Pharmacists' Utilization of Non-HDL-C Levels in Managing Patients With Lipid Disorders.34290861Nardolillo JA, Marrs JC, Anderson SL, Hanratty R, Saseen JJJRSM cardiovascular diseaseNardolillo JA, Marrs JC, Anderson SL, Hanratty R, Saseen JJ. Retrospective cohort study of statin prescribing for primary prevention among people living with HIV. JRSM Cardiovasc Dis. 2021 Jan-Dec; 10:20480040211031068.JRSM Cardiovasc Dis2021-07-12T00:00:002021Retrospective cohort study of statin prescribing for primary prevention among people living with HIV.34531060Grundy SM, Stone NJ, Blumenthal RS, Braun LT, Heidenreich PA, Lloyd-Jones D, Orringer CE, Saseen JJ, Smith SC, Sperling LS, Virani SSMayo Clinic proceedingsGrundy SM, Stone NJ, Blumenthal RS, Braun LT, Heidenreich PA, Lloyd-Jones D, Orringer CE, Saseen JJ, Smith SC, Sperling LS, Virani SS. High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better. Mayo Clin Proc. 2021 10; 96(10):2660-2670.Mayo Clin Proc2021-09-14T00:00:002021High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better.Authorship 251877234817786Williams B, Saseen JJ, Trujillo T, Palkimas SJournal of thrombosis and thrombolysisWilliams B, Saseen JJ, Trujillo T, Palkimas S. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome. J Thromb Thrombolysis. 2022 Jul; 54(1):67-73.J Thromb Thrombolysis2021-11-24T00:00:002021Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome.Authorship 255722335021920Courtney LA, Trujillo TC, Saseen JJ, Wright G, Palkimas SThe Annals of pharmacotherapyCourtney LA, Trujillo TC, Saseen JJ, Wright G, Palkimas S. Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge. Ann Pharmacother. 2022 09; 56(9):981-987.Ann Pharmacother2022-01-13T00:00:002022Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge.Authorship 255947835063437Virani SS, Koschinsky ML, Maher L, Mehta A, Orringer CE, Santos RD, Shapiro MD, Saseen JJProgress in cardiovascular diseasesVirani SS, Koschinsky ML, Maher L, Mehta A, Orringer CE, Santos RD, Shapiro MD, Saseen JJ. Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. Prog Cardiovasc Dis. 2022 Jul-Aug; 73:32-40.Prog Cardiovasc Dis2022-01-19T00:00:002022Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know.Authorship 257497335151418Williams L, Braun LT, Saseen JJ, Guyton JRJournal of clinical lipidologyWilliams L, Braun LT, Saseen JJ, Guyton JR. JCL Roundtable. The lipidology team. J Clin Lipidol. 2022 Jan-Feb; 16(1):3-12.J Clin Lipidol2022-01-01T00:00:002022JCL Roundtable. The lipidology team.Authorship 259802435430999Hill JB, Fixen C, Wright G, Saseen JJCurrent drug safetyHill JB, Fixen C, Wright G, Saseen JJ. Medications Associated with Occurrence of Urinary Tract Infections in Patients with Diabetes, Heart Failure or Both. Curr Drug Saf. 2023; 18(3):368-373.Curr Drug Saf2023-01-01T00:00:002023Medications Associated with Occurrence of Urinary Tract Infections in Patients with Diabetes, Heart Failure or Both.Authorship 262754435606075Mehta A, Jain V, Saeed A, Saseen JJ, Gulati M, Ballantyne CM, Virani SSAtherosclerosisMehta A, Jain V, Saeed A, Saseen JJ, Gulati M, Ballantyne CM, Virani SS. Lipoprotein(a) and ethnicities. Atherosclerosis. 2022 05; 349:42-52.Atherosclerosis2022-05-01T00:00:002022Lipoprotein(a) and ethnicities.Authorship 263883235718660Cheeley MK, Saseen JJ, Agarwala A, Ravilla S, Ciffone N, Jacobson TA, Dixon DL, Maki KCJournal of clinical lipidologyCheeley MK, Saseen JJ, Agarwala A, Ravilla S, Ciffone N, Jacobson TA, Dixon DL, Maki KC. NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient. J Clin Lipidol. 2022 Jul-Aug; 16(4):361-375.J Clin Lipidol2022-06-09T00:00:002022NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient.Authorship 264942435848505Trudeau BM, Allen LA, Billups SJ, Saseen JJ, Pearson SMJournal of pharmacy practiceTrudeau BM, Allen LA, Billups SJ, Saseen JJ, Pearson SM. Evaluation of Loop Diuretic Dosing Following Sodium-Glucose Cotransporter 2 Inhibitor Initiation in Patients With Heart Failure. J Pharm Pract. 2023 Dec; 36(6):1330-1335.J Pharm Pract2022-07-17T00:00:002022Evaluation of Loop Diuretic Dosing Following Sodium-Glucose Cotransporter 2 Inhibitor Initiation in Patients With Heart Failure.Authorship 230523Authorship 237372Authorship 2730832Authorship 276456136400235Lamprecht DG, Saseen JJ, Shaw PBProgress in cardiovascular diseasesLamprecht DG, Saseen JJ, Shaw PB. Clinical conundrums involving statin drug-drug interactions. Prog Cardiovasc Dis. 2022 Nov 15.Prog Cardiovasc Dis2022-11-15T00:00:002022Clinical conundrums involving statin drug-drug interactions.36503836Saseen JJ, Virani SSProgress in cardiovascular diseasesSaseen JJ, Virani SS. Lipid lowering therapy in 2022 and beyond - How far we have come. Prog Cardiovasc Dis. 2022 Nov-Dec; 75:1-3.Prog Cardiovasc Dis2022-11-01T00:00:002022Lipid lowering therapy in 2022 and beyond - How far we have come.Authorship 251623Authorship 256562Authorship 284154337353220Marrs JC, Orlando ST, Saseen JJ, Novins-Montague S, Sandy LC, Waughtal J, Glorioso TJ, Ho PMAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsMarrs JC, Orlando ST, Saseen JJ, Novins-Montague S, Sandy LC, Waughtal J, Glorioso TJ, Ho PM. Description of patient questions received by clinical pharmacists in the Nudge Study. Am J Health Syst Pharm. 2023 09 07; 80(18):1247-1254.Am J Health Syst Pharm2023-09-07T00:00:002023Description of patient questions received by clinical pharmacists in the Nudge Study.Authorship 275834true1ProfessorProfessortrue1ProfessorProfessortrue1Affiliate - DHHAAffiliate - DHHAtrue1ProfessorProfessorAuthorship 289546237542629Tandon A, Saseen JJ, Fink RM, Billups SJAIDS and behaviorTandon A, Saseen JJ, Fink RM, Billups SJ. Primary Care and Infectious Disease Provider Adherence to HIV Pre-exposure Prophylaxis (PrEP) Prescribing and Monitoring Recommendations. AIDS Behav. 2023 Aug 05.AIDS Behav2023-08-05T00:00:002023Primary Care and Infectious Disease Provider Adherence to HIV Pre-exposure Prophylaxis (PrEP) Prescribing and Monitoring Recommendations.true1Assoc Professor-ClinicalAssoc Professor-ClinicalAuthorship 288328Authorship 301121Authorship 303042Authorship 32169true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Clinical Assoc Professor Clinical Assoc Professor true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Clinical Assoc Professor Clinical Assoc Professor true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate ProfessorAuthorship 335372Authorship 3432Authorship 362416Authorship 106166124102728Saseen JJ, Ghushchyan V, Kaila S, Allen RR, Nair KVJournal of clinical hypertension (Greenwich, Conn.)Saseen JJ, Ghushchyan V, Kaila S, Allen RR, Nair KV. Maintaining goal blood pressures after switching from olmesartan to other angiotensin receptor blockers. J Clin Hypertens (Greenwich). 2013 Dec; 15(12):888-92.J Clin Hypertens (Greenwich)2013-09-19T00:00:002013Maintaining goal blood pressures after switching from olmesartan to other angiotensin receptor blockers.Authorship 374391Authorship 375261Authorship 376321Authorship 382027Authorship 399971Authorship 408051Authorship 424793Authorship 426794Authorship 43984Authorship 1081297Authorship 108266424122857Nigro SC, Garwood CL, Berlie H, Irons B, Longyhore D, McFarland MS, Saseen JJ, Trewet CBPharmacotherapyNigro SC, Garwood CL, Berlie H, Irons B, Longyhore D, McFarland MS, Saseen JJ, Trewet CB. Clinical pharmacists as key members of the patient-centered medical home: an opinion statement of the Ambulatory Care Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2014 Jan; 34(1):96-108.Pharmacotherapy2013-10-09T00:00:002013Clinical pharmacists as key members of the patient-centered medical home: an opinion statement of the Ambulatory Care Practice and Research Network of the American College of Clinical Pharmacy.24513421Thompson AM, Linnebur SA, Vande Griend JP, Saseen JJThe Consultant pharmacist : the journal of the American Society of Consultant PharmacistsThompson AM, Linnebur SA, Vande Griend JP, Saseen JJ. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult. Consult Pharm. 2014 Feb; 29(2):110-23.Consult Pharm2014-02-01T00:00:002014Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.Authorship 109484224761017Trujillo JM, Saseen JJ, Linnebur SA, Borgelt LM, Hemstreet BA, Fish DNAmerican journal of pharmaceutical educationTrujillo JM, Saseen JJ, Linnebur SA, Borgelt LM, Hemstreet BA, Fish DN. Impact of student- versus instructor-directed case discussions on student performance in a pharmacotherapy capstone course. Am J Pharm Educ. 2014 Apr 17; 78(3):56.Am J Pharm Educ2014-04-17T00:00:002014Impact of student- versus instructor-directed case discussions on student performance in a pharmacotherapy capstone course.Authorship 458222Authorship 460473Authorship 463354Authorship 464882Authorship 476462Authorship 109856224687542Ripley TL, Saseen JJThe Annals of pharmacotherapyRipley TL, Saseen JJ. ?-blockers: a review of their pharmacological and physiological diversity in hypertension. Ann Pharmacother. 2014 Jun; 48(6):723-33.Ann Pharmacother2014-03-31T00:00:002014?-blockers: a review of their pharmacological and physiological diversity in hypertension.Authorship 487882Authorship 489982Authorship 499281Authorship 110725224855392Kostoff MD, Saseen JJ, Borgelt LMInternational journal of women's healthKostoff MD, Saseen JJ, Borgelt LM. Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy. Int J Womens Health. 2014; 6:423-8.Int J Womens Health2014-04-28T00:00:002014Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy.Authorship 518902Authorship 521312Authorship 111459224915477Vande Griend JP, Saseen JJ, Bislip D, Moore G, Conry CFamily medicineVande Griend JP, Saseen JJ, Bislip D, Moore G, Conry C. An off-site clinical pharmacy service in family medicine: development and 1-year outcomes. Fam Med. 2014 May; 46(5):348-53.Fam Med2014-05-01T00:00:002014An off-site clinical pharmacy service in family medicine: development and 1-year outcomes.Authorship 524703Authorship 559242Authorship 566733Authorship 583155Authorship 584671Authorship 589184Authorship 5895710Authorship 6053Authorship 609923Authorship 639146Authorship 640942Authorship 642911Authorship 113732325083247Lowe RN, Marrs JC, Saseen JJTherapeutic advances in drug safetyLowe RN, Marrs JC, Saseen JJ. Patterns of serum laboratory monitoring for safety and efficacy in patients on chronic statin therapy. Ther Adv Drug Saf. 2013 Feb; 4(1):9-17.Ther Adv Drug Saf2013-02-01T00:00:002013Patterns of serum laboratory monitoring for safety and efficacy in patients on chronic statin therapy.Authorship 665734Authorship 114527325126268Nair KV, Miller K, Saseen J, Wolfe P, Allen RR, Park JAmerican health & drug benefitsNair KV, Miller K, Saseen J, Wolfe P, Allen RR, Park J. Prescription copay reduction program for diabetic employees: impact on medication compliance and healthcare costs and utilization. Am Health Drug Benefits. 2009 Jan; 2(1):14-24.Am Health Drug Benefits2009-01-01T00:00:002009Prescription copay reduction program for diabetic employees: impact on medication compliance and healthcare costs and utilization.Authorship 684281Authorship 689301Authorship 115406225177478King WM, Saseen JJ, Anderson SLTherapeutic advances in chronic diseaseKing WM, Saseen JJ, Anderson SL. Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Ther Adv Chronic Dis. 2014 Sep; 5(5):206-11.Ther Adv Chronic Dis2014-09-01T00:00:002014Characterization of diabetes risk factors in patients prescribed chronic statin therapy.Authorship 708202Authorship 729306Authorship 731564Authorship 733011Authorship 752825Authorship 766773